Bipartisan legislators introduced the ASAP Act to authorize Medicare coverage for FDA-approved blood-based biomarker tests aimed at the early detection of Alzheimer’s and other dementias.

ALZpath, Inc., a leader in blood test - based diagnostic solutions for Alzheimer's disease, today announced the expansion of its licensing agreement with Quanterix Corporation. The expanded agreement ...

A small study once suggested that differences between the two nostrils in detecting peanut butter might offer a clue to ...

From: Acting Head of KPSM Communication Department             Inspector F.N. Richards  . KPSM officers trained in assisting persons living with Alzheimer’s Disease The KPSM recently ...

The CDC reported 3.07 million U.S. deaths in 2024, with heart disease and cancer topping the list, suicide returning to the ...

The Kerala High Court, in a recent decision, appointed a guardian for a 93-year-old woman with dementia and Alzheimer's ...

This was how Andrew Denton spoke of what he calls the hardest conversation of all — voluntary assisted dying (VAD) for those ...

Atrial fibrillation (AF) is associated with major long-term complications, including ischaemic stroke and dementia. Over ...

A new study reveals that the active ingredient in drugs like Ozempic and Wegovy could lower the risk of developing Alzheimer’s disease.

SLED is investigating a Williamsburg County woman who is accused of using a fraudulent power of attorney to steal more than ...

People were about 19 percentage points less likely to recommend life-sustaining treatment for a seriously ill patient with ...

Explore how blood-based biomarkers perform across Alzheimer’s disease stages, including AIBL Study findings comparing ...